Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Mild cognitive impairment (MCI) represents early-stage Alzheimer's disease

Mild cognitive impairment (MCI) represents early-stage Alzheimer's disease Journal of Alzheimer’s Disease 7 (2005) 235–239 IOS Press Special Report from the Challenging Views of Alzheimer’s Disease John C. Morrisa and Jeffrey Cummingsb Washington University School of Medicine, 4488 Forest Park Avenue, Suite 130, St. Louis, Missouri 6108, USA Tel.: +1 314 286 2881; Fax: +1 314 286 2763; E-mail: morrisj@abraxas.wustl.edu b David Geffen School of Medicine at UCLA, University of California Los Angeles, 710 Westwood Plaza, Ste 2-238, Los Angeles, CA 90095-1769, USA Tel.: +1 310 206 5238; Fax: +1 310 206 5287; E-mail: jcummings@mednet.ucla.edu 1. Introduction Although the conclusive diagnosis of Alzheimer’s disease rests on clinicopathological correlation, much now is known about its clinical and behavioral symptoms. The current clinical diagnostic process can identify AD with high accuracy (90% or higher in autopsyconfirmed series from dementia research centers) [3]. Clinical diagnostic tools include a careful history of the presentation and course of dementia and potentially contributing conditions (e.g., stroke, depression, medications), objective tests of cognitive function, physical and neurological examinations, and a limited number of laboratory procedures (thyroid function tests, vitamin B12 levels, and neuroimaging). Standard diagnostic criteria and assessment procedures for AD have been published in a Practice Parameter by the American Academy of http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Alzheimer's Disease IOS Press

Mild cognitive impairment (MCI) represents early-stage Alzheimer's disease

Download PDF
5 pages

Loading next page...
 
/lp/ios-press/mild-cognitive-impairment-mci-represents-early-stage-alzheimer-s-5DEa0WTXax

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
IOS Press
Copyright
Copyright © 2005 by IOS Press, Inc
ISSN
1387-2877
eISSN
1875-8908
Publisher site
See Article on Publisher Site

Abstract

Journal of Alzheimer’s Disease 7 (2005) 235–239 IOS Press Special Report from the Challenging Views of Alzheimer’s Disease John C. Morrisa and Jeffrey Cummingsb Washington University School of Medicine, 4488 Forest Park Avenue, Suite 130, St. Louis, Missouri 6108, USA Tel.: +1 314 286 2881; Fax: +1 314 286 2763; E-mail: morrisj@abraxas.wustl.edu b David Geffen School of Medicine at UCLA, University of California Los Angeles, 710 Westwood Plaza, Ste 2-238, Los Angeles, CA 90095-1769, USA Tel.: +1 310 206 5238; Fax: +1 310 206 5287; E-mail: jcummings@mednet.ucla.edu 1. Introduction Although the conclusive diagnosis of Alzheimer’s disease rests on clinicopathological correlation, much now is known about its clinical and behavioral symptoms. The current clinical diagnostic process can identify AD with high accuracy (90% or higher in autopsyconfirmed series from dementia research centers) [3]. Clinical diagnostic tools include a careful history of the presentation and course of dementia and potentially contributing conditions (e.g., stroke, depression, medications), objective tests of cognitive function, physical and neurological examinations, and a limited number of laboratory procedures (thyroid function tests, vitamin B12 levels, and neuroimaging). Standard diagnostic criteria and assessment procedures for AD have been published in a Practice Parameter by the American Academy of

Journal

Journal of Alzheimer's Disease – IOS Press

Published: Jan 1, 2005

There are no references for this article.